33 web-programmer-developer-"https:"-"https:"-"https:"-"U.S" Fellowship positions at Nature Careers
Sort by
Refine Your Search
-
on the production and in vitro characterization of several enzymes in parallel (proteases and hydrolases). This research programme is part of an international effort to answer the call for the development of new
-
screening strategies being evaluated in large-scale clinical trials. The fellow will work under the mentorship of Drs. Elizabeth O’Donnell, MD, and Catherine Marinac, PhD, who oversee a research program
-
approach is transdisciplinary, transformative, and co-creative. The RIFS awards the Klaus Töpfer Sustainability Fellowship as part of its Fellow Programme. Prof. Dr Klaus Töpfer was the Founding Director of
-
is to define how inherited variation influences gene regulation, tumor evolution, and clinical cancer phenotypes towards the ultimate goal of earlier cancer detection and improved prevention strategies
-
The Cambridge Institute for Medical Research (CIMR) invites applications from postdoctoral researchers interested in sponsorship for career development fellowships that enable the establishment
-
status and have privileges to apply for external grants to expand their research program. The Fellows will have a strong support network and opportunities to build a highly interdisciplinary and
-
such as system usability, improved patient outcomes, and workflow optimization. Preference will be given to candidates who have completed a clinical informatics fellowship or similar advanced degree program
-
lab has an outstanding track record in developing and applying cutting-edge genetic, genomic, and systems biology approaches to study neurodegenerative disorders including HD and Alzheimer’s disease (AD
-
of T-cell-centered chemical immunology and has received major funding from the National Natural Science Foundation of China (including the Distinguished Young Scholars program). Recent work from the lab
-
autoantibodies in autoimmune disease pathology, to reveal the underlying mechanisms by which anti-MICL autoantibodies mediate their pathological effects and develop approaches to block the effect